$3.54
-0.11-3.01%
Last update: Nov 11, 4:18 AM
GoodRx Holdings Inc
GDRXNASDAQ
The average analyst price target for GoodRx Holdings is $5.79, 64.0% above the current price. Of 15 analysts, 7 rate it Buy, 6 Hold and 2 Sell. Targets range from $2.50 to $10. The latest change came on Aug 21, 2026, when Barclays raised its price target on GoodRx Holdings from $3 to $4 and kept an Underweight rating.
Price Target Range — 12 Quarters
Analyst Consensus — 15 Analysts
Rating Trend — Last 9 Months
